Rakesh Jhunjhunwala’s Company, Which Concord Biotech Funded, Applies for an IPO
Rakesh Jhunjhunwala, a late billionaire investor, was funded by Rare Enterprises. To earn money through an initial public offering (IPO), Concord Biotech has submitted its...